Gene · 4176
Papers3,001
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,001
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Matrix metalloproteinases in pituitary adenoma invasiveness]. | Probl Endokrinol (Mosk) | 2026 | 41834597 | PubTator, text mining | PubMed |
| Investigating the oncogenic potential of MTHFD2 in oral squamous cell carcinoma. | J Cancer Res Clin Oncol | 2026 | 41831033 | PubTator, text mining | PubMed |
| USP1 promotes hepatocellular carcinoma progression by modulating mitophagy via stabilizing MCM3 to regulate the Keap1-Nrf2 axis. | iScience | 2026 | 41797940 | PubTator, text mining | PubMed |
| Native chromatome profiling reveals hundreds of metabolic enzymes in the nucleus across tissues. | Nat Commun | 2026 | 41792114 | PubTator, text mining | PubMed |
FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | 41751958 | PubTator, text mining | PubMed |
| NGAL and HPV Subtypes in Cervical Carcinoma: Implications for Cancer Progression and Treatment Response. | Curr Issues Mol Biol | 2026 | 41751496 | PubTator, text mining | PubMed |
| Toxicogenomic Characterization of Perfluorooctanoic Acid-Associated Bladder Carcinogenesis. | Cell Biol Toxicol | 2026 | 41735763 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| Glycolysis enzymes and cellular lactylation in tumour. | Clin Transl Med | 2026 | 41705280 | PubTator, text mining | PubMed |
| Nucleolar protein 6 as a potential oncogenic factor in colorectal cancer. | PLoS One | 2026 | 41628115 | PubTator, text mining | PubMed |
| The multi-omics and Mendelian randomization analyses unveiled potential marker genes in the progression of glioblastoma. | Medicine (Baltimore) | 2026 | 41578499 | PubTator, text mining | PubMed |
| Mycobiont-specific primers for lichenized fungal genus Cladonia (Cladoniaceae, Ascomycota). | MycoKeys | 2026 | 41542016 | PubTator, text mining | PubMed |
| CircMCM7 Promotes Hepatocellular Carcinoma Cell Proliferation and Metastasis By Modulating MCM7 Expression. | J Biochem Mol Toxicol | 2026 | 41502012 | PubTator, text mining | PubMed |
| Design, synthesis and molecular docking of Pyrazolo[3,4-b]pyridine derivatives as potential CDK2 pathway inhibitors in colorectal cancer cells. | Bioorg Chem | 2026 | 41365064 | PubTator, text mining | PubMed |
| Biomarkers Driving Precision Medicine in Nonfunctioning Pituitary Neuroendocrine Tumors: A Systematic Review of Recent Literature. | J Clin Endocrinol Metab | 2026 | 41342334 | PubTator, text mining | PubMed |
| Histone Lactylation Promotes Proliferation and Migration of TNBC Cells via Upregulating MCM7 Transcription. | Tohoku J Exp Med | 2026 | 40738669 | PubTator, text mining | PubMed |
| Prioritizing missense mutations via a deep learning phosphorylation prediction model. | Hum Genomics | 2025 | 41469746 | PubTator, text mining | PubMed |
| Retraction Note: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth. | Cell Death Dis | 2025 | 41309534 | PubTator, text mining | PubMed |
| Integrated bioinformatic and machine learning analysis identifies MCM7 and ADAM17 as potential biomarkers for early stage gastric cancer. | J Gastrointest Oncol | 2025 | 41220724 | PubTator, text mining | PubMed |
| Deciphering splicing heterogeneity at single-cell resolution by SCSES. | Nat Commun | 2025 | 41145486 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4176/papers?page=2